TREM2 and Alzheimer disease: Previously, TREM2 was extensively studied and identified as a surface receptor required for microglia response to neurodegenerative changes, which has been associated with the pathogenesis of Alzheimer’s disease (AD) and other neurodegenerative diseases (NDDs) (3).